Le Lézard
Classified in: Health
Subjects: PSF, LGB, CFG

Government of Canada releases 2024-2030 Action Plan on Sexually Transmitted and Blood-Borne Infections


New funding of $2.45 million to support the priorities of the Action Plan.

OTTAWA, ON, Feb. 27, 2024 /CNW/ - Sexually transmitted and blood-borne infections (STBBI) are largely preventable, treatable, and in many cases curable. However, rates of sexually transmitted infections in Canada have increased over the last decade?gonorrhea rates have doubled since 2012, and syphilis rates are five times what they were.

That is why today, the Honourable Mark Holland, Minister of Health, launched the Government of Canada's sexually transmitted and blood-borne infections (STBBI) action plan 2024-2030 and announced $2.45 million in funding to address STBBI in Canada. Incorporating the input of multiple consultations with members of key populations, health care professionals and many others, the priorities of the Action Plan include:

The new $2.45 million in funding to support the priorities of the Action Plan, includes $1.45 million for community-based organizations to create and deliver their own targeted syphilis-specific resources and awareness-raising activities, as well as $1 million to the Canadian Institutes of Health Research (CIHR) to support syphilis research projects.

STBBI remain a significant public health concerns in Canada, as they can have sexual, reproductive and maternal-child health consequences, including genital and extragenital symptoms, pregnancy complications, cancer, infertility and psychosocial impacts. The Government also recognizes that STBBI do not affect all people equally because of differing social, economic and other factors. This is why Canada takes a whole-of-government approach and considers the underlying structural inequalities and determinants of health as part of its efforts to address STBBI.

Quotes

"Everyone in Canada should have access to the sexual and reproductive health services they need, no matter who they are or where they live. Our Action Plan, developed in consultation with key populations, healthcare professionals, and the latest innovations in science will guide how the federal government will work to address and end STBBI as public health concerns. "

The Honourable Mark Holland
Minister of Health

"We are proud to announce the launch of the Action Plan which will improve the health of people in Canada, and to support key populations known to be disproportionally affected by STBBI. The Action Plan will continue to work towards reducing STBBI related stigma, to prevent new and reoccurring infections and connect people to testing, prevention, treatment and care."

The Honourable Ya'ara Saks
Minister of Mental Health and Addictions and Associate Minister of Health

"Rates of sexually transmitted and blood-borne infections are influenced by socio-economic conditions and risk factors such as housing insecurity, rural or remote residence, lower income, substance use, experiences of violence, lack of access to health care, and stigma. It is our collective responsibility to normalize discussions about sexual health, drive positive change and meet our global goal of ending AIDS, viral hepatitis and sexually transmitted infections as public health concerns by 2030."

Dr. Theresa Tam
Chief Public Health Officer of Canada

Associated Links

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 11:40
Growing a robust, competitive, domestic biomanufacturing and life sciences sector ensures that Canada has access to critical vaccines, therapeutics and other life-saving medicines. The Government of Canada has been doing just that since the launch of...

at 11:38
On Saturday, May 11, hundreds of hikers and mountain bikers will hit the trails in China Camp State Park to raise funds and awareness about the North Bay's critical need for mental healthcare. The 3rd annual Bike + Hike 4 Buckelew is hosted by...

at 11:35
Vasomune Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of AV-001 for the treatment of diseases associated with vascular dysfunction, today announced that the Company will present a Late-Breaking scientific...

at 11:35
NOMADX Holdings, LLC, a company pioneering new technologies for biological and chemical detection, announced today that it has initiated an early access program for its portable NOMADX platform which aims to enable faster, more accurate on-site...

at 11:34
Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose forms and formulations of products to serve the needs of overlooked patients, announced today that the U.S. Food and Drug Administration (FDA) has approved...

at 11:32
The board of directors of Eli Lilly and Company has declared a dividend for the second quarter of 2024 of $1.30 per share on outstanding common stock. The dividend is payable on June 10, 2024, to shareholders of record at the close of business...



News published on and distributed by: